Global Transcatheter Mitral Valve Replacement (TMVR) Market Size & Trends Report Segmented by Product Type (Mechanical Valves, Bioprosthetic/Tissue Valves), Indication (Functional Mitral Regurgitation, Degenerative Mitral Regurgitation), End User, & Regional Forecast to 2030
The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast period. Major factors driving growth include increased prevalence of mitral valve diseases, growing preferences for minimally invasive procedures, advancements in TMVR technology, growing geriatric population, increasing clinical trials & regulatory approvals for TMVR devices, and favorable reimbursement policies for TMVR procedures. To learn more about the research report, download a sample report.
Report Overview
Transcatheter Mitral Valve Replacement (TMVR) is a minimally invasive procedure designed to replace a damaged or diseased mitral valve in the heart. As one of the four heart valves regulating blood flow between chambers, the mitral valve plays a crucial role in circulation. When it becomes compromised, it can lead to blood leakage into the lungs, causing symptoms such as shortness of breath, fatigue, and fluid buildup.
During TMVR, a new valve is delivered through a catheter, typically inserted via an artery in the groin or chest. Using advanced imaging techniques like X-ray or echocardiography, the catheter is carefully guided to the heart. Once positioned, the new valve is expanded and secured within the existing valve structure, restoring proper blood flow. TMVR can be performed using two main techniques:
- Native Valve Replacement: An investigational approach that directly replaces the patient’s original mitral valve
- Valve-in-Valve Replacement: A method used to implant a new valve within a failing prosthetic valve or a previously placed annuloplasty ring from prior surgery
To learn more about the research report, download a sample report.
The increasing prevalence of mitral valve diseases drives market growth
The increasing prevalence of mitral valve diseases, particularly mitral regurgitation (MR) and mitral stenosis (MS), is becoming a significant global health concern. Factors such as an aging population, rising incidences of cardiovascular diseases, and lifestyle-related conditions like hypertension and obesity contribute to the growing burden of these disorders. A 2023 ScienceDirect article states that mitral regurgitation, the most prevalent valvular heart disease, impacts approximately 2% of the general population and up to 10% of individuals over 75, frequently resulting in heart failure if untreated. Additionally, mitral stenosis remains a major issue in developing regions due to persistent cases of rheumatic heart disease. Many of these conditions progress silently, resulting in late-stage diagnosis and the need for advanced interventions. As surgical treatments pose high risks for elderly and comorbid patients, the demand for minimally invasive solutions such as transcatheter mitral valve replacement (TMVR) is rising, driving innovation and growth in the global TMVR market.
To learn more about the research report, download a sample report.
Growing preference for minimally invasive procedures in TMVR fuels its demand
The growing preference for minimally invasive procedures in transcatheter mitral valve replacement (TMVR) is transforming the landscape of mitral valve disease treatment. Unlike traditional open-heart surgery, which involves significant risks, long recovery times, and potential complications, TMVR offers a less invasive alternative with reduced hospital stays and faster patient recovery. Advancements in catheter-based technology, imaging guidance, and procedural techniques have made TMVR a viable option for high-risk patients who are ineligible for conventional surgery. Additionally, the increasing awareness of patient-centric care and the demand for quicker, less painful treatments are driving the adoption of minimally invasive TMVR. As healthcare systems prioritize cost-effective solutions with better clinical outcomes, the shift toward minimally invasive interventions is expected to accelerate, further boosting the growth of the TMVR market.
Competitive Landscape Analysis
The global transcatheter mitral valve replacement (TMVR) market is marked by the presence of established and emerging market players such as Abbott Laboratories; Edwards Lifesciences; Medtronic plc; Boston Scientific Corporation; LivaNova; Cardiac Dimensions; NeoChord, Inc.; Opus Medical Therapies, LLC; HighLife Medical; and Neovasc; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.
Report Scope
|
Report Scope |
Details |
|
Base Year Considered |
2024 |
|
Historical Data |
2023 – 2024 |
|
Forecast Period |
2025 – 2030 |
|
Growth Rate |
20% |
|
Market Drivers |
|
|
Attractive Opportunities |
|
|
Segment Scope |
 Product Type, Indication, and End User |
|
Regional Scope |
|
|
Key Companies Mapped |
Abbott Laboratories; Edwards Lifesciences; Medtronic plc; Boston Scientific Corporation; LivaNova; Cardiac Dimensions; NeoChord, Inc.; Opus Medical Therapies, LLC; HighLife Medical; and Neovasc |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global transcatheter mitral valve replacement (TMVR) market at the regional- and country level from 2023 to 2030. The report further segments the market based on product type, indication, and end user.
- Market Size & Forecast (2023-2030), By Product Type, USD Million
- Mechanical Valves
- Bioprosthetic/Tissue Valves
- Market Size & Forecast (2023-2030), By Indication, USD Million
- Functional Mitral Regurgitation (FMR)
- Degenerative Mitral Regurgitation (DMR)
- Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cardiac Catheterization Laboratories
- Others
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the transcatheter mitral valve replacement (TMVR) market?
- What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the transcatheter mitral valve replacement (TMVR) market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction​
- Market Scope​
- Market Definition​
- Segments Covered​
- Regional Segmentation​
- Research Timeframe​
- Currency Considered​
- Study Limitations​
- Stakeholders​
- List of Abbreviations​
- Key Conferences and Events (2025-2026)​
- Research Methodology​
- Secondary Research​
- Primary Research​
- Market Estimation​
- Bottom-Up Approach​
- Top-Down Approach​
- Market Forecasting​
- Executive Summary
- Transcatheter Mitral Valve Replacement (TMVR) Market Snapshot (2025-2030)​
- Segment Overview​
- Regional Snapshot​
- Competitive Insights ​
- Market Overview
- Market Dynamics
- Drivers
- Increased prevalence of mitral valve diseases
- Growing preferences for minimally invasive procedures
- Advancements in TMVR technology
- Growing geriatric population
- Increasing clinical trials & regulatory approvals for TMVR devices
- Favorable reimbursement policies for TMVR procedures
- Restraints​
- High cost of mitral valve surgical procedures
- Strict regulatory requirements for novel device approvals
- Potential risks and complications associated with the TMVR procedure
- Opportunities​
- Development of next-generation TMVR devices
- Expansion into emerging markets
- Growing applications in heart failure management
- Drivers
- Market Dynamics
-
- Key Market Trends​
- Advancement in 3D printing and computational modeling
- Adoption of AI & imaging technologies in enhancing TMVR procedures
- Unmet Market Needs​
- Industry Speaks​
- Key Market Trends​
- Global Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), By Product Type, USD Million
- Introduction​
- Mechanical Valves
- Bioprosthetic/Tissue Valves
- Global Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), By Indication, USD Million
- Introduction​
- Functional Mitral Regurgitation (FMR)
- Degenerative Mitral Regurgitation (DMR)
- Global Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction​
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cardiac Catheterization Laboratories
- Others
- Global Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction​
- North America Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), By Country, USD Million​
- US​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Canada​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- US​
- Europe Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), By Country, USD Million​
- UK ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Germany ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- France ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Italy ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Spain ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- UK ​
- Asia Pacific (APAC) Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), By Country, USD Million​
- China ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Japan ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- India ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific ​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- China ​
- Latin America (LATAM) Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Transcatheter Mitral Valve Replacement (TMVR) Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Product Type (USD Million)​
- Market Size & Forecast, By Indication (USD Million)​
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corporation
- Edwards Lifesciences
- LivaNova
- Cardiac Dimensions
- NeoChord, Inc.
- Opus Medical Therapies, LLC
- HighLife Medical
- Neovasc
- Other Prominent Players
  Note: *Indicative list
  **For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Ambulatory Surgical Centers (ASCs), Academic & Research Institutes, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts.
Data Triangulation
Research findings derived through secondary sources & internal analysis were validated with Primary Interviews, the Internal Knowledge Repository, and the Company’s Sales Data.
